LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.

Social and economic factors may drive COVID-19 hospitalization risk more than HIV status among reproductive-age women in the Southern US.

Phase 3 trial results show BIC/LEN is noninferior to BIC/FTC/TAF for maintaining virologic suppression in adults with HIV.

Real-world data show an ibalizumab-based regimen provides sustained virologic suppression in heavily treatment-experienced ...

Updated 2024-2025 COVID-19 vaccines significantly reduced the risk for hospitalization and severe outcomes despite the emergence of new viral lineages.

Switching to a once-daily fixed-dose combination of DOR/ISL maintains high rates of virologic suppression through 96 weeks in HIV-1.

The Trump administration is pulling $600 million in CDC funding from California, Colorado, Illinois, and Minnesota to align ...

Research shows newborn hepatitis B vaccine refusal declined from 12.1% to 3.5%, although rates varied widely across different hospital systems.

Injectable cabotegravir + rilpivirine reduced regimen failure risk compared with daily oral therapy in patients with HIV and adherence challenges.

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

Hims & Hers says it will stop selling a copy of a new weight-loss pill after federal officials raised concerns.

Most nonretired RNs said adequate staffing (65%), flexible scheduling (59%), and better wages and benefits (59%) would increase their likelihood of returning.